The worldwide Udder Health Market stood at USD 1.19 billion in 2023, and is projected to reach USD 1.95 billion by 2031, recording a CAGR of 6.5% from 2024 through 2031.
Udder Health covers reshaping how healthcare entities approach this space.
Growth is driven by a convergence of factors: rising awareness among end users, continuous product innovation, and the growing emphasis on efficiency and sustainability within the healthcare sector.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region projected to deliver the strongest growth trajectory through the forecast period, driven by demographic shifts and policy support.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Udder Health Market Snapshot
Chapter 4. Global Udder Health Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Product Estimates & Trend Analysis
5.1. By Product & Market Share, 2023 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Product:
5.2.1. Devices
5.2.2. Pharmaceuticals
5.2.3. Supplements
Chapter 6. Market Segmentation 2: By Veterinary Care Setting Estimates & Trend Analysis
6.1. By Veterinary Care Setting & Market Share, 2023 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Veterinary Care Setting:
6.2.1. Dairy Farms
6.2.2. Veterinary Hospitals & Clinics
Chapter 7. Market Segmentation 3: By Animal Type Estimates & Trend Analysis
7.1. By Animal Type & Market Share, 2023 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Animal Type:
7.2.1. Dairy Cattle
7.2.2. Other Animals(Goat, Sheep, etc)
Chapter 8. Market Segmentation 4: by Disease Type Estimates & Trend Analysis
8.1. by Disease Type & Market Share, 2023 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Disease Type:
8.2.1. Clinical Mastitis
8.2.2. Other Disease Types (Subclinical & Chronic)
Chapter 9. Udder Health Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Udder Health Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031
9.1.2. North America Udder Health Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2024-2031
9.1.3. North America Udder Health Market Revenue (US$ Million) Estimates and Forecasts by Veterinary Care Setting, 2024-2031
9.1.4. North America Udder Health Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2024-2031
9.1.5. North America Udder Health Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.2. Europe
9.2.1. Europe Udder Health Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031
9.2.2. Europe Udder Health Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2024-2031
9.2.3. Europe Udder Health Market Revenue (US$ Million) Estimates and Forecasts by Veterinary Care Setting, 2024-2031
9.2.4. Europe Udder Health Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2024-2031
9.2.5. Europe Udder Health Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.3. Asia Pacific
9.3.1. Asia Pacific Udder Health Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031
9.3.2. Asia Pacific Udder Health Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2024-2031
9.3.3. Asia Pacific Udder Health Market Revenue (US$ Million) Estimates and Forecasts by Veterinary Care Setting, 2024-2031
9.3.4. Asia Pacific Udder Health Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2024-2031
9.3.5. Asia Pacific Udder Health Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.4. Latin America
9.4.1. Asia Pacific Udder Health Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031
9.4.2. Asia Pacific Udder Health Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2024-2031
9.4.3. Latin America Udder Health Market Revenue (US$ Million) Estimates and Forecasts by Veterinary Care Setting, 2024-2031
9.4.4. Latin America Udder Health Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2024-2031
9.4.5. Latin America Udder Health Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.5. Middle East & Africa
9.5.1. Middle East & Africa Udder Health Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031
9.5.2. Middle East & Africa Udder Health Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2024-2031
9.5.3. Middle East & Africa Udder Health Market Revenue (US$ Million) Estimates and Forecasts by Veterinary Care Setting, 2024-2031
9.5.4. Middle East & Africa Udder Health Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2024-2031
9.5.5. Middle East & Africa Udder Health Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Vetoquinol S.A. (France),
10.2.2. Zoetis Inc. (US),
10.2.3. Merck & Co., Inc. (US),
10.2.4. Virbac (France),
10.2.5. Ecolab (US),
10.2.6. Boehringer Ingelheim GmbH (Germany),
10.2.7. Elanco Animal Health Incorporated (US),
10.2.8. DeLaval (Sweden),
10.2.9. Orffa (Netherlands),
10.2.10. AHV International (Netherlands),
10.2.11. Boumatic LLC (US),
10.2.12. GEA Group Aktiengesellschaft (Germany),
10.2.13. G Shepherd Animal Health (UK),
10.2.14. Ceva Sante Animale (France),
10.2.15. Albert Kerbl GmbH (Germany),
10.2.16. Ambic Equipment Limited (England),
10.2.17. Lely (Netherlands),
10.2.18. Zenex Animal Health India Private Limited (India),
10.2.19. Draminski S.A. (Poland),
10.2.20. Ring Biotechnology Co Ltd. (China),
10.2.21. Nicosia Biolabs International Private Limited (India),
10.2.22. Blackmango Herb (India),
10.2.23. Koru Diagnostics Ltd. (New Zealand),
10.2.24. Mastaplex (New Zealand),
10.2.25. AR Brown Co., Ltd. (Japan).
10.2.26. Other Prominent Players